190 related articles for article (PubMed ID: 31840306)
1. Cancer-Cell-Specific Drug Delivery by a Tumor-Homing CPP-Gossypol Conjugate Employing a Tracelessly Cleavable Linker.
Maity SK; Stahl P; Hensel A; Knauer S; Hirschhäuser C; Schmuck C
Chemistry; 2020 Mar; 26(14):3010-3015. PubMed ID: 31840306
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
3. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
4. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.
Dragojevic S; Turner L; Raucher D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216417
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment.
Deng X; Mai R; Zhang C; Yu D; Ren Y; Li G; Cheng B; Li L; Yu Z; Chen J
Eur J Med Chem; 2021 Mar; 213():113050. PubMed ID: 33280896
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of gossypol related compounds.
Dao VT; Gaspard C; Mayer M; Werner GH; Nguyen SN; Michelot RJ
Eur J Med Chem; 2000 Sep; 35(9):805-13. PubMed ID: 11006482
[TBL] [Abstract][Full Text] [Related]
7. Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.
Shi NQ; Qi XR
ACS Appl Mater Interfaces; 2017 Mar; 9(12):10519-10529. PubMed ID: 28290666
[TBL] [Abstract][Full Text] [Related]
8. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies on gossypol in tumor cell lines.
Shelley MD; Hartley L; Groundwater PW; Fish RG
Anticancer Drugs; 2000 Mar; 11(3):209-16. PubMed ID: 10831280
[TBL] [Abstract][Full Text] [Related]
10. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
11. Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy.
Wei Y; Ma L; Zhang L; Xu X
Int J Nanomedicine; 2017; 12():7039-7051. PubMed ID: 29026300
[TBL] [Abstract][Full Text] [Related]
12. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
[TBL] [Abstract][Full Text] [Related]
13. A liposomal delivery vehicle for the anticancer agent gossypol.
Zhai G; Wu J; Zhao X; Yu B; Li H; Lu Y; Ye W; Lin YC; Lee RJ
Anticancer Res; 2008; 28(5A):2801-5. PubMed ID: 19035313
[TBL] [Abstract][Full Text] [Related]
14. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
15. Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study.
Ryu JS; Kratz F; Raucher D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498762
[TBL] [Abstract][Full Text] [Related]
16. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
[TBL] [Abstract][Full Text] [Related]
17. Design of a new pH-activatable cell-penetrating peptide for drug delivery into tumor cells.
Zhang Y; Li L; Chang L; Liu H; Song J; Liu Y; Bao H; Liu B; Wang R; Ni J
Chem Biol Drug Des; 2019 Sep; 94(5):1884-1893. PubMed ID: 31062442
[TBL] [Abstract][Full Text] [Related]
18. Novel O-glycosidic gossypol isomers and their bioactivities.
Yin J; Jin L; Chen F; Wang X; Kitaygorodskiy A; Jiang Y
Carbohydr Res; 2011 Oct; 346(14):2070-4. PubMed ID: 21788013
[TBL] [Abstract][Full Text] [Related]
19. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.
Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y
Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775
[TBL] [Abstract][Full Text] [Related]
20. Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines.
Shelley MD; Hartley L; Fish RG; Groundwater P; Morgan JJ; Mort D; Mason M; Evans A
Cancer Lett; 1999 Jan; 135(2):171-80. PubMed ID: 10096426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
